Table 1.
Parameters evaluated in the study in PCOS patients.
| Parameters | PCOS Patients n = 94 Mean ± SD |
|---|---|
| Age (years) | 24.12 ± 3.68 |
| Anthropometric measurements | |
| BMI (kg/m2) | 38.23 ± 6.62 |
| WC (cm) | 117.66 ± 19.53 |
| Nutritional parameters | |
| PREDIMED score | 5.56 ± 2.25 |
| Total energy intake (kcal) | 2636.09 ± 415.77 |
| Inflammatory parameter | |
| hs-CRP levels (mg/L) | 3.61 ± 4.19 |
| Hormonal parameters | |
| Testosterone (ng/dL) | 54.79 ± 11.51 |
| Insulin (μU/mL) | 19.17 ± 14.99 |
| Metabolic parameters | |
| Fasting glucose (mg/dL) | 104.94 ± 15.21 |
| Total cholesterol (mg/dL) | 200.55 ± 38.91 |
| HDL-cholesterol (mg/dL) | 37.61 ± 11.06 |
| LDL-cholesterol (mg/dL) | 129.27 ± 41.15 |
| Triglycerides (mg/dL) | 168.38 ± 50.79 |
| ALT (U/L) | 41.74 ± 19.10 |
| AST (U/L) | 41.31 ± 18.37 |
| γGT (U/L) | 39.93 ± 21.31 |
| Cardio-metabolic indices | |
| HoMA-IR | 5.32 ± 4.59 |
| VAI | 4.51 ± 2.44 |
| FLI | 87.60 ± 14.04 |
| Metabolic Syndrome | |
| MetS (number parameter) | 3.13 ± 1.22 |
| Clinical Hyperandrogenism | |
| Ferriman-Gallwey score | 19.61 ± 8.18 |
| Body composition | |
| R (Ω) | 460.39 ± 84.64 |
| Xc (Ω) | 43.79 ± 9.47 |
| PhA (°) | 5.47 ± 0.75 |
PCOS, Polycystic Ovarian Syndrome; BMI, Body Mass Index; WC, Waist Circumference; PREDIMED, PREvención con DIetaMEDiterránea; hs-CRP, high-sensitivity C-reactive Protein; HDL, High-density Lipoprotein; LDL, Low-Density Lipoprotein; ALT, Alanine Transaminase; AST, Aspartate Aminotransferase; γGT; γ-Glutamyltransferase; HoMA-IR, Homeostasis model assessment insulin resistance; VAI, Visceral Adiposity Index; FLI; Fatty Liver Index; MetS, Metabolic Syndrome; R, Resistance; Xc, Reactance; PhA, Phase angle; SD, standard deviation.